Cheerleading commentary and raw opinion on bio-business and molecular medicine.
Wednesday, August 29, 2012
Biotech’s Capital Intensity Challenge: A Post-Mortem on 2007’s Biggest Deals
Truth from Booth: there is no correlation between the amount of venture capital raised by a biotech and it's ultimate outcome.
I suspect that huge VC rounds just incent management to take on more risks beyond their control.
Read Bruce's full article here:
Sent from Pocket -
Get it free!
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)